A cluster randomized controlled trial comparing relative effectiveness of two licensed influenza vaccines in US nursing homes: Design and rationale

Clinical Trials

Volumn 13, Issue 3, 2016, Pages 264-274

  Gravenstein, Stefan ^a,b   Dahal, Roshani ^b   Gozalo, Pedro L ^b   Edward Davidson, H ^c   Han, Lisa F ^c   Taljaard, Monica ^d,e   Mor, Vincent ^b,f  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b BROWN UNIVERSITY   (United States)

^c Insight Therapeutics   (United States)

^d OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^e UNIVERSITY OF OTTAWA   (Canada)

^f PROVIDENCE VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

cluster randomized trial; elderly; high dose; Influenza; influenza vaccine; long stay residents; long term care; nursing home; randomized controlled trial

Indexed keywords

INFLUENZA VACCINE;

AGE; AGED; ARTICLE; ASTHMA; CAUCASIAN; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLUSTER ANALYSIS; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEPRESSION; DIABETES MELLITUS; DRUG DOSE COMPARISON; DRUG MEGADOSE; FACTORIAL DESIGN; FEMALE; FLU LIKE SYNDROME; FUNCTIONAL ASSESSMENT; HEALTH CARE SYSTEM; HEART FAILURE; HOSPITALIZATION; HUMAN; HYPERTENSION; INFLUENZA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICARE; MORTALITY; MULTICENTER STUDY; NURSING HOME; NURSING HOME PATIENT; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; STUDY DESIGN; VERY ELDERLY; COMPARATIVE STUDY; SINGLE BLIND PROCEDURE; UNITED STATES;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; FEMALE; HOSPITALIZATION; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MEDICARE; MORTALITY; NURSING HOMES; SINGLE-BLIND METHOD; UNITED STATES;

EID: 84966593238     PISSN: 17407745     EISSN: 17407753     Source Type: Journal    
DOI: 10.1177/1740774515625976     Document Type: Article

References (67)

1. Nichol KL, Wuorenma J, Von Sternberg VT., Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Arch Intern Med 1998; 158: 1769-1776.
2. Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA 2004; 292: 1333-1340.
3. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289: 179-186.
4. Nicholson KG., Impact of influenza and respiratory syncytial virus on mortality in England and Wales from January 1975 to December 1990. Epidemiol Infect 1996; 116: 51-63.
5. Thompson MG, Shay DK, Zhou H, et al. Estimates of deaths associated with seasonal influenza-United States, 1976-2007. Morb Mortal Wkly Rep 2010; 59: 1057-1062.
6. Dao CN, Kamimoto L, Nowell M, et al. Adult hospitalizations for laboratory-positive influenza during the 2005-2006 through 2007-2008 seasons in the United States. J Infect Dis 2010; 202: 881-888.
7. Strausbaugh LJ, Sukumar SR, Joseph CL., Infectious disease outbreaks in nursing homes: an unappreciated hazard for frail elderly persons. Clin Infect Dis 2003; 36: 870-876.
8. Kostova D, Reed C, Finelli L, et al. Influenza illness and hospitalizations averted by influenza vaccination in the United States, 2005-2011. PLoS ONE 2013; 8: e66312.
9. Lavallee P, Perchaud V, Gautier-Bertrand M, et al. Association between influenza vaccination and reduced risk of brain infarction. Stroke 2002; 33: 513-518.
10. Clar C, Oseni Z, Flowers N, et al. Influenza vaccines for preventing cardiovascular disease. Cochrane Database Syst Rev 2015; 5: CD005050.
11. Beyer WE, McElhaney J, Smith DJ, et al. Cochrane re-arranged: support for policies to vaccinate elderly people against influenza. Vaccine 2013; 31: 6030-6033.
12. Graverholt B, Forsetlund L, Jamtvedt G., Reducing hospital admissions from nursing homes: a systematic review. BMC Health Serv Res 2014; 14: 36.
13. Jefferson T, Di Pietrantonj C, Al-Ansary LA, et al. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 2010; 2: CD004876.
14. Goodwin K, Viboud C, Simonsen L., Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006; 24: 1159-1169.
15. Keitel WA, Atmar RL, Cate TR, et al. Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons. Arch Intern Med 2006; 166: 1121-1127.
16. Falsey AR, Treanor JJ, Tornieporth N, et al. Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older. J Infect Dis 2009; 200: 172-180.
17. DiazGranados CA, Dunning AJ, Kimmel M, et al. Efficacy of high-dose versus standard-dose influenza vaccine in older adults. N Engl J Med 2014; 371: 635-645.
18. Izurieta HS, Thadani N, Shay DK, et al. Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis. Lancet Infect Dis 2015; 15: 293-300.
19. University of Pittsburgh. Randomized trial of high dose influenza vaccine in long term care setting (NCT01654224)., http://clinicaltrials.gov/show/NCT01654224 (2011,. accessed 10 June 2014).
20. Insight Therapeutics LLC. High dose influenza vaccine in nursing homes-a clustered randomized trial (NCT01815268)., http://clinicaltrials.gov/ct2/show/NCT01815268 (2013,. accessed 10 June 2015).
21. Nace DA, Lin CJ, Ross TM, et al. Randomized, controlled trial of high-dose influenza vaccine among frail residents of long-term care facilities. J Infect Dis 2015; 211: 1915-1924.
22. Loeb M, Carusone SC, Goeree R, et al. Effect of a clinical pathway to reduce hospitalizations in nursing home residents with pneumonia: a randomized controlled trial. JAMA 2006; 295: 2503-2510.
23. Loeb M, Brazil K, Lohfeld L, et al. Effect of a multifaceted intervention on number of antimicrobial prescriptions for suspected urinary tract infections in residents of nursing homes: cluster randomised controlled trial. BMJ 2005; 331: 669.
24. Hanson LC, Carey TS, Caprio AJ, et al. Improving decision-making for feeding options in advanced dementia: a randomized, controlled trial. J Am Geriatr Soc 2011; 59: 2009-2016.
25. Ersek M, Polissar N, Pen AD, et al. Addressing methodological challenges in implementing the nursing home pain management algorithm randomized controlled trial. Clin Trials 2012; 9: 634-644.
26. Van Ness PH, Peduzzi PN, Quagliarello VJ., Efficacy and effectiveness as aspects of cluster randomized trials with nursing home residents: methodological insights from a pneumonia prevention trial. Contemp Clin Trials 2012; 33: 1124-1131.
27. Boorsma M, Frijters DH, Knol DL, et al. Effects of multidisciplinary integrated care on quality of care in residential care facilities for elderly people: a cluster randomized trial. CMAJ 2011; 183: E724-E732.
28. O'Halloran PD, Cran GW, Beringer TR, et al. A cluster randomised controlled trial to evaluate a policy of making hip protectors available to residents of nursing homes. Age Ageing 2004; 33: 582-588.
29. Kerse N, Butler M, Robinson E, et al. Fall prevention in residential care: a cluster, randomized, controlled trial. J Am Geriatr Soc 2004; 52: 524-531.
30. Beer C, Horner B, Flicker L, et al. A cluster-randomised trial of staff education to improve the quality of life of people with dementia living in residential care: the DIRECT study. PLoS ONE 2011; 6: e28155.
31. Sackley CM, Burton CR, Herron-Marx S, et al. A cluster randomised controlled trial of an occupational therapy intervention for residents with stroke living in UK care homes (OTCH): study protocol. BMC Neurol 2012; 12: 52.
32. Donner A, Birkett N, Buck C., Randomization by cluster. Sample size requirements and analysis. Am J Epidemiol 1981; 114: 906-914.
33. Donner A, Klar N., Design and analysis of cluster randomization trials in health research. London: Arnold Publishing Co; 2000.
34. Loeb MB., Application of the development stages of a cluster randomized trial to a framework for valuating complex health interventions. BMC Health Serv Res 2002; 2: 13.
35. Taljaard M, McRae AD, Weijer C, et al. Inadequate reporting of research ethics review and informed consent in cluster randomised trials: review of random sample of published trials. BMJ 2011; 342: d2496.
36. Taljaard M, Weijer C, Grimshaw JM, et al. The Ottawa statement on the ethical design and conduct of cluster randomised trials: précis for researchers and research ethics committees. BMJ 2013; 346: f2838.
37. Hawes C, Morris JN, Phillips CD, et al. Development of the nursing home resident assessment instrument in the USA. Age Ageing 1997; 26 (Suppl. 2): 19-25.
38. Mor V, Angelelli J, Gifford D, et al. Benchmarking and quality in residential and nursing homes: lessons from the US. Int J Geriatr Psychiatry 2003; 18: 258-266.
39. Mor V, Berg K, Angelelli J, et al. The quality of quality measurement in U.S. nursing homes. Gerontologist 2003; 43 (Spec no 2): 37-46.
40. Mor V, Angelelli J, Jones R, et al. Inter-rater reliability of nursing home quality indicators in the U.S. BMC Health Serv Res 2003; 3: 20.
41. Roy J, Mor V., The effect of provider-level ascertainment bias on profiling nursing homes. Stat Med 2005; 24: 3609-3629.
42. Mor V., Improving the quality of long-term care with better information. Milbank Q 2005; 83: 333-364.
43. Liperoti R, Gambassi G, Lapane KL, et al. Conventional and atypical antipsychotics and the risk of hospitalization for ventricular arrhythmias or cardiac arrest. Arch Intern Med 2005; 165: 696-701.
44. Intrator O, Grabowski DC, Zinn J, et al. Hospitalization of nursing home residents: the effects of states' Medicaid payment and bed-hold policies. Health Serv Res 2007; 42: 1651-1671.
45. Cai S, Feng Z, Fennell ML, et al. Despite small improvement, black nursing home residents remain less likely than whites to receive flu vaccine. Health Aff 2011; 30: 1939-1946.
46. Rahman M, Tyler D, Acquah JK, et al. Sensitivity and specificity of the Minimum Data Set 3.0 discharge data relative to Medicare claims. J Am Med Dir Assoc 2014; 15: 819-824.
47. Mor V, Gruneir A, Feng Z, et al. The effect of state policies on nursing home resident outcomes. J Am Geriatr Soc 2011; 59: 3-9.
48. Lima JC, Intrator O, Karuza J, et al. Nursing home medical staff organization and 30-day rehospitalizations. J Am Med Dir Assoc 2012; 13: 552-557.
49. Centers for Medicare & Medicaid Services. Long term care Minimum Data Set (MDS). Baltimore, MD: Centers for Medicare & Medicaid Services, 2012.
50. Thomas KS, Wysocki A, Intrator O, et al. Finding Gertrude: the resident's voice in Minimum Data Set 3.0. J Am Med Dir Assoc 2014; 15: 802-806.
51. Rahman M, Zinn JS, Mor V., The impact of hospital-based skilled nursing facility closures on rehospitalizations. Health Serv Res 2013; 48: 499518.
52. Feng Z, Jung HY, Wright B, et al. The origin and disposition of Medicare observation stays. Med Care 2014; 52: 796-800.
53. Asher NR, White DB., Quality in quality improvement research-a new benchmark. Crit Care 2011; 15: 316.
54. Gozalo PL, Pop-Vicas A, Feng Z, et al. Effect of influenza on functional decline. J Am Geriatr Soc 2012; 60: 1260-1267.
55. Kahan BC., Bias in randomised factorial trials. Stat Med 2013; 32: 4540-4549.
56. Raab GM, Day S, Sales J., How to select covariates to include in the analysis of a clinical trial. Control Clin Trials 2000; 21: 330-342.
57. Begg MD, Parides MK., Separation of individual-level and cluster-level covariate effects in regression analysis of correlated data. Stat Med 2003; 22: 2591-2602.
58. Wei LJ, Lin DY, Weissfeld L., Regression analysis of multivariate incomplete failure time data by modeling marginal distributions. J Am Stat Assoc 1989; 84: 1065-1073.
59. Zou GY, Donner A., Extension of the modified Poisson regression model to prospective studies with correlated binary data. Stat Methods Med Res 2013; 22: 661-670.
60. Pop-Vicas A, Rahman M, Gozalo PL, et al. Estimating the effect of influenza vaccination on nursing home residents' morbidity and mortality. J Am Geriatr Soc 2015; 63: 1798-1804.
61. Hayes RJ, Bennett S., Simple sample size calculation for cluster-randomized trials. Int J Epidemiol 1999; 28: 319-326.
62. Simonsen L, Taylor RJ, Viboud C, et al. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis 2007; 7: 658-666.
63. Osterholm MT, Kelley NS, Sommer A, et al. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12: 36-44.
64. Jefferson T, Rivetti D, Rivetti A, et al. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet 2005; 366: 1165-1174.
65. Jackson LA, Jackson ML, Nelson JC, et al. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol 2006; 35: 337-344.
66. Thomas RE, Jefferson T, Lasserson TJ., Influenza vaccination for healthcare workers who work with the elderly. Cochrane Database Syst Rev 2010; 2: CD005187.
67. Whelan PJ, Walwyn R, Gaughran F, et al. Impact of the demand for 'proxy assent' on recruitment to a randomised controlled trial of vaccination testing in care homes. J Med Ethics 2013; 39: 36-40.